BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28545143)

  • 21. [Cytolethal distending toxins].
    Curová K; Kmeťová M; Siegfried L
    Epidemiol Mikrobiol Imunol; 2014 Jun; 63(2):134-9. PubMed ID: 25025680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro.
    Yamamoto K; Tominaga K; Sukedai M; Okinaga T; Iwanaga K; Nishihara T; Fukuda J
    Eur J Oral Sci; 2004 Oct; 112(5):445-51. PubMed ID: 15458505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the interaction among the components of the cytolethal distending toxin of Haemophilus ducreyi.
    Deng K; Latimer JL; Lewis DA; Hansen EJ
    Biochem Biophys Res Commun; 2001 Jul; 285(3):609-15. PubMed ID: 11453636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest.
    Elwell C; Chao K; Patel K; Dreyfus L
    Infect Immun; 2001 May; 69(5):3418-22. PubMed ID: 11292766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems.
    Lewis DA; Stevens MK; Latimer JL; Ward CK; Deng K; Blick R; Lumbley SR; Ison CA; Hansen EJ
    Infect Immun; 2001 Sep; 69(9):5626-34. PubMed ID: 11500438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea.
    Shima A; Hinenoya A; Asakura M; Sugimoto N; Tsukamoto T; Ito H; Nagita A; Faruque SM; Yamasaki S
    Infect Immun; 2012 Apr; 80(4):1323-32. PubMed ID: 22252871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internalization of the Active Subunit of the
    Boesze-Battaglia K; Walker LP; Dhingra A; Kandror K; Tang HY; Shenker BJ
    Front Cell Infect Microbiol; 2017; 7():469. PubMed ID: 29184850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LRRC8A promotes
    Mao W; Wang Z; Wen S; Lin Y; Gu J; Sun J; Wang H; Cao Q; Xu Y; Xu X; Cai X
    Virulence; 2023 Dec; 14(1):2287339. PubMed ID: 38018865
    [No Abstract]   [Full Text] [Related]  

  • 29.
    Le LHM; Elgamoudi B; Colon N; Cramond A; Poly F; Ying L; Korolik V; Ferrero RL
    Microbiol Spectr; 2024 Mar; 12(3):e0323223. PubMed ID: 38319111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins.
    Bachran C; Hasikova R; Leysath CE; Sastalla I; Zhang Y; Fattah RJ; Liu S; Leppla SH
    Cell Death Dis; 2014 Jan; 5(1):e1003. PubMed ID: 24434511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assembly and function of a bacterial genotoxin.
    Nesić D; Hsu Y; Stebbins CE
    Nature; 2004 May; 429(6990):429-33. PubMed ID: 15164065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid-induced disassembly of the Haemophilus ducreyi cytolethal distending toxin.
    Huhn GR; Sparkes C; Silva I; Reyes C; Perez G; Khondker F; Jones T; Fragoso A; Contreras P; Alvarez M; Zabala-Rodriguez MC; Tatulian SA; Teter K
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):57-63. PubMed ID: 36332483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest.
    Elwell CA; Dreyfus LA
    Mol Microbiol; 2000 Aug; 37(4):952-63. PubMed ID: 10972814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new variant of cytolethal distending toxin in a clinical isolate of Campylobacter hyointestinalis.
    Samosornsuk W; Kamei K; Hatanaka N; Taguchi T; Asakura M; Somroop S; Sugimoto N; Chaicumpa W; Yamasaki S
    J Med Microbiol; 2015 Oct; 64(10):1124-1134. PubMed ID: 26220191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit.
    McSweeney LA; Dreyfus LA
    Cell Microbiol; 2004 May; 6(5):447-58. PubMed ID: 15056215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconstitution and purification of cytolethal distending toxin of Actinobacillus actinomycetemcomitans.
    Saiki K; Konishi K; Gomi T; Nishihara T; Yoshikawa M
    Microbiol Immunol; 2001; 45(6):497-506. PubMed ID: 11497226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin.
    Ueno Y; Ohara M; Kawamoto T; Fujiwara T; Komatsuzawa H; Oswald E; Sugai M
    Infect Immun; 2006 Jun; 74(6):3480-7. PubMed ID: 16714579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo virulence properties of bacterial cytolethal-distending toxin.
    Ge Z; Schauer DB; Fox JG
    Cell Microbiol; 2008 Aug; 10(8):1599-607. PubMed ID: 18489725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of intrachain disulfides in the activities of the CdtA and CdtC subunits of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans.
    Cao L; Volgina A; Korostoff J; DiRienzo JM
    Infect Immun; 2006 Sep; 74(9):4990-5002. PubMed ID: 16926390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between clinico-pathological outcome and typing of Haemophilus parasuis field strains.
    Aragon V; Cerdà-Cuéllar M; Fraile L; Mombarg M; Nofrarías M; Olvera A; Sibila M; Solanes D; Segalés J
    Vet Microbiol; 2010 May; 142(3-4):387-93. PubMed ID: 19945233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.